State Street Corp. Files SC 13G for Alkermes plc Stock
Ticker: ALKS · Form: SC 13G · Filed: 2024-01-24T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**State Street just disclosed a passive stake in Alkermes, signaling institutional interest.**
AI Summary
State Street Corporation, a major financial institution, reported an initial beneficial ownership filing (SC 13G) on January 24, 2024, for Alkermes plc. This filing indicates State Street's holdings of Alkermes' common stock as of December 31, 2023. While the exact percentage isn't specified in the provided text, this type of filing typically signifies a passive investment by a large institutional investor, which can be a positive signal of institutional confidence for current and prospective Alkermes shareholders.
Why It Matters
This filing shows that a significant institutional investor, State Street Corporation, holds a notable position in Alkermes plc, which can be interpreted as a vote of confidence in the company's future.
Risk Assessment
Risk Level: low — An SC 13G filing by an institutional investor like State Street Corporation generally indicates a passive stake and does not suggest any immediate risk or activist intent.
Analyst Insight
An investor should note that State Street Corporation, a large institutional player, has disclosed a passive stake in Alkermes plc. While this doesn't indicate activist intent, it suggests institutional confidence and could be a factor to consider when evaluating Alkermes' stock, though further research into the size of the stake would be beneficial.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Alkermes plc (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G
FAQ
What type of filing is this document?
This document is an SC 13G filing, specifically an 'INITIAL FILING' under the Securities Exchange Act of 1934, as stated on the first page of the filing.
Who is the reporting person in this SC 13G filing?
The reporting person is STATE STREET CORPORATION, as clearly identified under 'NAME OF REPORTING PERSON' on page 2 of 5.
What is the subject company whose securities are being reported?
The subject company is ALKERMES PLC, identified as the 'NAME OF ISSUER' on the first page of the filing.
What is the CUSIP number for the securities reported?
The CUSIP number for the common stock of Alkermes plc is 01642T108, as stated on the first page and page 2 of 5 of the filing.
What was the date of the event that required this filing?
The date of the event which required this filing was 12/31/2023, as specified under 'DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT' on the first page.
From the Filing
EDGAR Filing Documents for 0000093751-24-000130 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G - Statement of Beneficial Ownership by Certain Investors: SEC Accession No. 0000093751-24-000130 Filing Date 2024-01-24 Accepted 2024-01-24 09:53:08 Documents 1 Document Format Files Seq Description Document Type Size 1 Alkermes_PLC.txt SC 13G 6540 Complete submission text file 0000093751-24-000130.txt 8663 Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000 STATE STREET CORP (Filed by) CIK : 0000093751 (see all company filings) EIN. : 042456637 | State of Incorp.: MA | Fiscal Year End: 1231 Type: SC 13G SIC : 6022 State Commercial Banks (CF Office: 02 Finance) Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000 Alkermes plc. (Subject) CIK : 0001520262 (see all company filings) EIN. : 981007018 | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005-86627 | Film No.: 24554693 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)